← Eichor
Study identifier: NCT07205991 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

ADHERE Trial: Strategies to Improve Mobile App Adherence

Condition: Low Back Pain  ·  Sponsor: Neuroscience Research Australia

PhaseNA
Planned participants258
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study aims to evaluate the effectiveness of two communication interventions, compared to standard app notifications, in increasing adherence to a mobile health app among individuals with chronic low back pain. The main question it aims to answer is: Do phone calls or text messages increase adherence compared to app notifications in patients receiving a digital health intervention for chronic back pain? Participants will: A) Receive pain education and clinical hypnosis via a mobile app for managing chronic LBP; B) Will be contacted up to twice via phone call or text message, or they will only receive standard notifications from the app.

This description comes directly from the study's public registry record.

Talk to the study team

James H McAuley, PhD  ·  +61293991266  ·  j.mcauley@neura.edu.au

Rodrigo RN Rizzo, PhD  ·  (02) 9399 1000  ·  r.rizzo@neura.edu.au

Always discuss trial participation with your own doctor first.

Locations (1)

Neuroscience Research AustraliaSydney, New South Wales, AustraliaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07205991